Background: Because of the expected increase in the number of people with dementia, and the associated social and economic costs, there is an urgent need to develop effective and cost-effective care for people with dementia and their caregivers. The intervention proposed here combines two approaches to caregiver support that have shown to be effective in empowering caregivers, i.e.
View Article and Find Full Text PDFBackground: Tick-borne diseases (TBDs) are a serious threat to humans, wildlife and livestock, and cause severe economic losses in many tropical drylands. The effective control of TBDs has been constrained by limited understanding of what determines tick loads in animals. We tested interactive effects of several biological factors (sex, age and body condition), one environmental factor (rainfall) and one human factor (management type) on tick loads in animals.
View Article and Find Full Text PDFEquine influenza virus (EIV) is a major cause of respiratory disease in horses. Vaccination is an effective tool for infection control. Although various EIV vaccines are widely available, major outbreaks occurred in Europe in 2018 involving a new EIV H3N8 FC1 strain.
View Article and Find Full Text PDFWeather conditions can impact infectious disease transmission, causing mortalities in humans, wild and domestic animals. Although rainfall in dry tropical regions is highly variable over the year, rainfall is thought to play an important role in the transmission of tick-borne diseases. Whether variation in rainfall affects disease-induced mortalities, is, however, poorly understood.
View Article and Find Full Text PDFVaccination is an effective tool to limit equine influenza virus (EIV H3N8) infection, a contagious respiratory disease with potentially huge economic impact. The study assessed the effects of antigenic change on vaccine efficacy and the need for strain update. Horses were vaccinated (V1 and V2) with an ISCOMatrix-adjuvanted, whole inactivated virus vaccine (Equilis Prequenza, group 2, FC1 and European strains) or a carbomer-adjuvanted, modified vector vaccine (ProteqFlu, group 3, FC1 and FC2 HA genes).
View Article and Find Full Text PDF